Assessment of juvenile idiopathic arthritis outcomes and place of residence in Canada: identifying disparities in care
Project Period:
2022-2024
Grant Category:
Health Equity Research Grant
Disease Area:
Juvenile Idiopathic Arthritis (JIA)
Juvenile idiopathic arthritis (JIA) affects approximately 8000 Canadian children and it can lead to chronic pain and life-long disability. Attaining full control of pain and inflammation as soon as possible is essential to offer children with arthritis the best chance of a productive pain-free life. Where a family lives may be a barrier to accessing arthritis care and achieving timely control of a child’s joint pain and inflammation. In this study, we will use information volunteered by hundreds of Canadian children and parents from a national JIA Registry and information about home neighborhood characteristics from Statistics Canada. We will look at barriers to care related to geographic location and associated sociodemographic factors, and how this impacts timely control of pain and inflammation.
Investigators
Roberta Berard, MD
London Health Sciences CentreRelated Awarded Grants
Disease Area:
Juvenile Idiopathic Arthritis (JIA)
Genetic Ancestry Powered studies (GAPs) in JIA
Disease Area:
Juvenile Idiopathic Arthritis (JIA)
Pilot of Adalimumab Withdrawal
Disease Area:
Juvenile Idiopathic Arthritis (JIA)